AlloVir ALVR

$ 0.57 0.84%

Quarterly report 2024-Q3
added 11-12-2024

AlloVir Financial Statements 2011-2024 | ALVR

Annual Financial Statements AlloVir

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	81.2 M	476 M	812 M	1.36 B	-	-	-	-	-	-	-	-	-
Shares	104 M	76.7 M	62.8 M	37.1 M	-	-	-	-	-	-	-	-	-
Historical Prices	0.78	6.21	12.9	38.4	-	-	-	-	-	-	-	-	-
Net Income	-190 M	-169 M	-172 M	-69.8 M	-23.8 M	-2.43 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	165 K	1.14 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-200 M	-171 M	-170 M	-71.3 M	-26.7 M	-	-	-	-	-	-	-	-
Interest Expense	3.62 M	351 K	-2.45 M	195 K	797 K	-	-	-	-	-	-	-	-
EBITDA	-200 M	-170 M	-170 M	-71.2 M	-16.1 M	-565 K	-	-	-	-	-	-	-
Operating Expenses	200 M	171 M	170 M	71.3 M	26.9 M	4.73 M	-	-	-	-	-	-	-
General and Administrative Expenses	48.3 M	52.3 M	49.1 M	21.6 M	10.6 M	3.03 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement AlloVir

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	115 M	115 M	115 M	114 M	114 M	94.6 M	93.3 M	93.1 M	84.9 M	64.5 M	64 M	63.6 M	63 M	62.3 M	62.2 M	61.9 M	40.5 M	2.63 M	2.22 M	2.1 M	1.46 M	1.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.13 M	-6.08 M	-30.3 M	-	-44.3 M	-45.3 M	-41.2 M	-	-42.1 M	-44.6 M	-43.9 M	-	-45.5 M	-37.6 M	-30.9 M	-	-23.6 M	-11.6 M	-9.34 M	-	-7.27 M	-5.3 M	-2.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	165 K	165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.72 M	-7.77 M	-32.3 M	-	-47 M	-47.3 M	-43.2 M	-	-43 M	-44.6 M	-43.2 M	-	-45.5 M	-37.7 M	-30.9 M	-	-23.9 M	-12.2 M	-9.84 M	-	-8.48 M	-5.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	100 K	338 K	754 K	-	1.17 M	521 K	723 K	-	210 K	-27 K	-818 K	-	-259 K	-408 K	-565 K	-	174 K	355 K	44 K	-	427 K	140 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-43.1 M	-	-42.3 M	-44.6 M	-42.7 M	-	-45.4 M	-37.7 M	-30.8 M	-	-23.8 M	-12.1 M	-9.82 M	-	-8.48 M	-5.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	7.77 M	32.3 M	-	47 M	47.3 M	43.2 M	-	43 M	44.6 M	43.2 M	-	45.5 M	37.7 M	30.9 M	-	23.9 M	12.2 M	9.84 M	-	8.48 M	5.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.88 M	7.17 M	10.7 M	-	12.8 M	12.5 M	12.5 M	-	12.9 M	13.2 M	14.1 M	-	12.4 M	12 M	10.5 M	-	6.72 M	3.27 M	3 M	-	2.82 M	3.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency